AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Randy Ellingson who wrote (712)	6/9/1998 8:53:00 PM
From: Doug (Htfd,CT)	Read Replies (1) of 1728

The bearish Forbes article is in the June 15 issue and is online at forbes.com It is complimentary of Zaffaroni's past history, but raises skepticism that he can pull off a coup the third time, in competition with Synteni, which may have a lower cost structure. The article concludes: "It is highly probable that DNA chips will be a godsend to medicine. It's not clear that this godsend will drop to Affymetrix's bottom line. " Doug (no position in AFFX)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next